Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HRD-Positive Advanced Ovarian Cancer
Clinical trial NCT07647653 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07647653
- Sponsor
- Shandong University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2031-02-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.